Global Protein Therapeutics Market 2016-2020 - Global Market 2016, Trend, Demand, Forecast 2025, Analysis
"Global
Protein Therapeutics Market 2016-2020"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
Technavios
market research analyst predicts the global protein therapeutics
market to grow steadily at a CAGR of 8% during the forecast period.
Increased demand for and use of monoclonal antibodies is expected to
drive the growth of the protein therapeutics market as it accounts
for more than half of the protein therapeutics market. The monoclonal
antibodies can be prepared specific to any cell surface or
extracellular target. These antibodies are being used in
radioimmunotherapy and antibody-directed enzyme prodrug therapy.
Monoclonal antibodies are also used in the formulation of various
biopharmaceutical drugs for the treatment of different diseases such
as cancer, rheumatoid arthritis, multiple sclerosis, and UC.
The
availability of favorable reimbursement policies in this market is
expected to boost the market growth during the forecast period.
Protein therapeutics are expensive and cannot be afforded by all, but
reimbursement of the diagnostic kits and biologic drugs are expected
to fuel the market during the forecast period. Plans like the public
reimbursement programs reduce the financial burden of treatments. The
reimbursement status of drugs varies from region to region, with
factors such as lack of cost-effectiveness impeding the coverage.
Product
segmentation and analysis of the protein therapeutics market
Monoclonal
antibodies
Erythropoietin
Insulin
Human
growth hormone
Interferons
Blood
clotting factor
G-CSF
Follicle
stimulating hormone
The
monoclonal antibodies segment dominated the market during 2015, with
a market share of 55%. An increase in the prevalence of cancer and
autoimmune diseases, increase in research activities, and increased
technological advancement in the development of next-generation
antibodies are the main factors fueling the growth of this segment.
Geographical
segmentation and analysis of the protein therapeutics market
Americas
APAC
EMEA
The
Americas accounted for 48% of the market share during 2015 and is
expected to grow at a CAGR of 7% during the forecast period. The
promising public health approaches by the government, growing
incidence, and an increase in regulatory support for the development
of protein therapeutics are the primary drivers for the market growth
in this region.
Comments
Post a Comment